Glioma specialists in Israel report surgical success rates of 85–90% for tumor removals at JCI-accredited centers. These outcomes are driven by neurosurgeons using brain mapping and intraoperative MRI to maximize resection. For low-grade gliomas, many Israeli clinics report 5-year survival rates reaching up to 90%.
- Surgical precision. Dr. Zvi Ram at Sourasky uses brain mapping to protect vital speech and motor functions.
- Specialized training. Dr. Felix Bokstein holds a five-year neuro-oncology specialization for managing complex brain tumors.
- Advanced radiation. Dr. Yaacov Lawrence at Sheba uses precision radiosurgery to target tumors while sparing healthy tissue.
- Oncological research. Dr. Zvi Cohen founded a brain tumor tissue bank to improve personalized treatment outcomes.
Bookimed Expert Insight: Israeli specialists often combine surgical mastery with intensive research in gene-based and immune therapies. For example, Dr. Zvi Ram researches gene-based treatments, and Dr. Dvora Blumental trained at Memorial Sloan-Kettering. This dual focus allows doctors to offer innovative options when standard protocols for aggressive gliomas show limited results.
Patient Consensus: Patients find hope in long-term survival stories, including those who remain tumor-free for 10+ years. Many choose Israel to access clinical trials or immunotherapy when conventional options feel insufficient. Families often notice the stability of outcomes for low-grade cases, where some stay disease-free for years.